Stocks in Action: Dermapharm, SMA Solar, BMW, ASML, Deutsche Börse
Reading Time: 4 minutes
Stock 1.) Dermapharm - BaFin investigation causes significant price drop! Significant declines were noticeable on Friday for Dermapharm. As was made known in the morning, BaFin has initiated an examination of the annual financial statements and the management report of the pharmaceutical manufacturer Dermapharm for the year 2025. Concrete indications have arisen that Dermapharm may have violated accounting regulations, according to the authority. This concerns the representation of a receivable including associated interest claims amounting...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
